Efficacy and safety of herbal bath for mild-to-moderate atopic dermatitis: A randomized, double-blind, placebo-controlled trial
Journal of Integrative Medicine · 2026-10
DOI: 10.1016/j.joim.2026.10.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Integrative Medicine, 2026-10. Verfasst von Zhen Duan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Center, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200443, China; School of Public Health, Sha…. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Previous studies have suggested the potential of a traditional Chinese herbal bath, known as Mushengshu (MSS), for alleviating atopic dermatitis (AD) symptoms, but high-quality evidence is lacking. OBJECTIVE: This study evaluates the efficacy and safety of MSS combined with foundational therapies in patients with mild-to-moderate AD. DESIGN, SETTING, PARTICIPANTS AND INTERVENTIONS: A total of 66 patients with mild-to-moderate AD were enrolled between August and December 2025 and were randomly assigned in a 2:1 ratio to the MSS group (n = 44) or the placebo group (n = 22). Patients received MSS or placebo once daily for 4 months. Meanwhile, the desonide cream for mild AD and triamcinolone acetonide cream for moderate AD were combined with urea ointment and applied twice daily for 2 weeks. MAIN OUTCOME MEASURES: The primary outcome was the proportion of patients who achieved ≥50% improvement in their Eczema Area and Severity Index (EASI) score from baseline to week 4 (EASI 50). Secondary outcomes included the continuous change in EASI scores, EASI 75/90 response rates, visual analogue scale (VAS), Investigator's Global Assessment (IGA) and Dermatology Life Quality Index (DLQI), assessed at weeks 0, 1, 2, 4 and 16. Data analysis was performed in line with the intention-to-treat principle. RESULTS: The EASI 50 response rate at week 4 was significantly higher in the MSS group than in the placebo group (70.5% vs 45.5%, P < 0.05) and similar statistically significant improvements were observed in the EASI 75 and EASI 90 response rates (P < 0.05). Nevertheless, compared to the placebo group, the MSS group had significantly lower median scores in the EASI, VAS, IGA and DLQI and a higher EASI 90 response rate (70.5% vs 45.5%) than the placebo (P < 0.05), and there were no adverse events reported. CONCLUSION: The results suggest that MSS combined with foundational therapies may be a beneficial adjuvant treatment for mild-to-moderate AD, providing support for its incorporation into comprehensive disease management. TRIAL REGISTRATION: International Traditional Medicine Clinical Trial Registry ITMCTR2025001206. Please cite this article as: Duan Z, Cai RQ, Shen FLZ, Lu JR, Xu QR, Zhang R, Gao XJ, Li B. Wang RP. Efficacy and safety of herbal bath for mild-to-moderate atopic dermatitis: A randomized, double-blind, placebo-controlled trial. J Integr Med. 2026; Epub ahead of print.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Research Center, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200443, China; School of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai 200443, Chi…
- School of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai 200443, China.
- Clinical Research Center, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200443, China.
- Clinical Research Center, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200443, China. Electronic address: l8930568129@163.com.
Zitieren
APA
Duan, Z., Cai, R. Q., Shen, F. L., Lu, J., Xu, Q. R., Zhang, R., Gao, X. J., Li, B., & Wang, R. P. (2026). Efficacy and safety of herbal bath for mild-to-moderate atopic dermatitis: A randomized, double-blind, placebo-controlled trial. Journal of Integrative Medicine. https://doi.org/10.1016/j.joim.2026.10.005
Vancouver
Duan Z, Cai RQ, Shen FL, Lu J, Xu QR, Zhang R, et al. Efficacy and safety of herbal bath for mild-to-moderate atopic dermatitis: A randomized, double-blind, placebo-controlled trial. Journal of Integrative Medicine. 2026. doi:10.1016/j.joim.2026.10.005
BibTeX
@article{Duan2026,
author = {Duan, Zhen and Cai, Rui-Qi and Shen, Fan-Ling-Zi and Lu, Jinrong and Xu, Quan-Ruo and Zhang, Rui and Gao, Xiang-Jin and Li, Bin and Wang, Rui-Ping},
title = {Efficacy and safety of herbal bath for mild-to-moderate atopic dermatitis: A randomized, double-blind, placebo-controlled trial},
journal = {Journal of Integrative Medicine},
year = {2026},
doi = {10.1016/j.joim.2026.10.005}
}
EUVIMED